Roflumilast Tablets (VA-27-00006601)
Closed Pre-Solicitation Posted
- Solicitation number
- 36E79726Q0005
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is conducting market research for a national mandatory requirements contract for Roflumilast Tablets to serve the VA, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Center, with responses due by September 17, 2026 at 2:30 PM Central Time. The resulting contract will block other companies offering the same or similar products from ordering, and the government intends to award pricing lower than Federal Supply Schedule or open market rates based on committed volume purchases.
Offerors must possess a unique eleven-digit National Drug Code with the first five digits identifying the offeror; the successful contractor's label shall be the only label on the product. If not the manufacturer, offerors must submit a manufacturer's letter of commitment guaranteeing sufficient supply for the contract period. All ordering activities under VA and DoD acquire pharmaceuticals through the Pharmaceutical Prime Vendor Program. Respondents must confirm U.S. manufacturing or Trade Agreements Act compliance and business size classification under NAICS 325412.
The procurement covers three line items: Roflumilast 250 MCG tablets in 28-count bottles (11,870 annual units); Roflumilast 500 MCG tablets in 30-count bottles (18,916 annual units); and Roflumilast 500 MCG tablets in 90-count bottles (13,880 annual units). All products require unit-of-use packaging with childproof closures, minimum 120cc bottle volume, cylindrical bottles with 5.75-inch minimum circumference, and labels measuring 5.25" x 2". Contractors must begin supply within 60 days of contract award. The anticipated contract structure includes a base year plus up to four option years. Direct responses to Kenneth Lay, Contract Specialist, at Kenneth.Lay@va.gov.
Notice text
I am conducting market research for the procurement of Roflumilast Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
- Is your Company able to meet the following minimum requirements:
- National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor’s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________
- If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________
- Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________
- Under NAICS code 325412, is your company size (check one):
Large Business ______
Small Business ______
- If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________
- Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________
- Can your company meet the following product, bottle size and usage? Please indicate any details or comments.
___________________________________________________________
___________________________________________________________
Files
| File | Type | Posted |
|---|---|---|
| 36E79726Q0005 RFI mod.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity